Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
2013 Standout
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Identification of a Retinal Aldosterone System and the Protective Effects of Mineralocorticoid Receptor Antagonism on Retinal Vascular Pathology
2008
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
2013 Standout
The role of calcium-independent phospholipase A2 in cardiolipin remodeling in the spontaneously hypertensive heart failure rat heart
2009
Selective Aldosterone Blockade Suppresses Atrial Tachyarrhythmias in Heart Failure
2006
Aldosterone Stimulates Reactive Oxygen Species Production through Activation of NADPH Oxidase in Rat Mesangial Cells
2005
Roles of individual prolyl‐4‐hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: insights from genetically modified mice
2012 StandoutNobel
Late breaking heart failure trials from the 2003 ACC meeting: EPHESUS and COMPANION
2003
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 Standout
A Novel Intracellular Membrane-Bound Calcium-Independent Phospholipase A2
2000
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction
2006 Standout
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
2010 Standout
Ischemic stroke in the elderly: an overview of evidence
2010
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Antagonists of Aldosterone and Proteinuria in Patients With CKD: An Uncontrolled Pilot Study
2005
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Inhibition of Ca2+‐independent phospholipase A2 by bromoenol lactone attenuates prostaglandin generation induced by interleukin‐1β and dibutyryl cAMP in rat mesangial cells
1998
A Novel Cytosolic Calcium-independent Phospholipase A2 Contains Eight Ankyrin Motifs
1997
Finerenone, a Novel Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Protects From Rat Cardiorenal Injury
2014
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Store-Operated Calcium Channels
2005 Standout
Diabetic Retinopathy
2012 Standout
Adipokines in inflammation and metabolic disease
2011 Standout
Identification of Calcium-independent Phospholipase A2 (iPLA2) β, and Not iPLA2γ, as the Mediator of Arginine Vasopressin-induced Arachidonic Acid Release in A-10 Smooth Muscle Cells
2002
Improving the efficacy of RAAS blockade in patients with chronic kidney disease
2012
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
The human calcium‐independent phospholipase A2 gene
1999
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
A Molecular Redox Switch on p21
1997
Echocardiographic assessment of age-associated changes in systolic and diastolic function of the female F344 rat heart
2004
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial
2019
Hypoxia-inducible Factor 1α (HIF-1α) Protein Is Rapidly Degraded by the Ubiquitin-Proteasome System under Normoxic Conditions
1997 Standout
Identification of the Calmodulin-binding Domain of Recombinant Calcium-independent Phospholipase A2β
2001
Secondary Prevention after Ischemic Stroke or Transient Ischemic Attack
2012
The Highly Selective Production of 2-Arachidonoyl Lysophosphatidylcholine Catalyzed by Purified Calcium-independent Phospholipase A2γ
2005
CIF and other mysteries of the store-operated Ca2+-entry pathway
2005
Human Calcium-independent Phospholipase A2 Mediates Lymphocyte Proliferation
2000
Function and Inhibition of Intracellular Calcium-independent Phospholipase A2
1997
Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
2003 Standout
Statins as Anti-Inflammatory Agents in Atherogenesis: Molecular Mechanisms and Lessons from the Recent Clinical Trials
2012
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function
2007
Drug Insight: translating evidence on statin therapy into clinical benefits
2008
Aldosterone and end-organ damage
2005
The effect of high molecular phospholipase A2 inhibitors on 3T6 fibroblast proliferation
2001
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
Biomarkers in Heart Failure
2008 Standout
Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis
2019
Bromoenol Lactone Inhibits Magnesium-dependent Phosphatidate Phosphohydrolase and Blocks Triacylglycerol Biosynthesis in Mouse P388D1 Macrophages
1996
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
2015 Standout
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
The clinical implications of aldosterone escape in congestive heart failure
2004
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Platelet Activation and Blood Coagulation
2002
Adiponectin Deficiency, Diastolic Dysfunction, and Diastolic Heart Failure
2009
Mice deficient in LMAN1 exhibit FV and FVIII deficiencies and liver accumulation of α1-antitrypsin
2011 StandoutNobel
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
2019 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
2013 Standout
Trends in Prescription Drug Use Among Adults in the United States From 1999-2012
2015 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
The murine platelet and plasma factor V pools are biosynthetically distinct and sufficient for minimal hemostasis
2003
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 Standout
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Mechanisms of Diabetic Complications
2013 Standout
Putting polyphosphates to the test: evidence against platelet-induced activation of factor XII
2013 StandoutNobel
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Nitroso–Redox Interactions in the Cardiovascular System
2006
Recipes for Creating Animal Models of Diabetic Cardiovascular Disease
2007
Mineralocorticoid Receptor Inhibition Ameliorates the Transition to Myocardial Failure and Decreases Oxidative Stress and Inflammation in Mice With Chronic Pressure Overload
2005
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Statin Treatment and Stroke Outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial
2009
Aldosterone and end-organ damage
2007
Nonalcoholic Fatty Liver Disease
2015 Standout
Inclusion of Stroke in Cardiovascular Risk Prediction Instruments
2012
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation
2009
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Aldosterone Activates Vascular p38MAP Kinase and NADPH Oxidase Via c-Src
2005
Works of Amy E. Rudolph being referenced
Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial by Stroke Subtypes
2009
Abstract 2985: Lipoprotein, Blood Pressure and Stroke Risk: Findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study
2006
Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats
2003
Multimodality therapy of an acquired factor V inhibitor
1996
Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial
2008
Nitric Oxide Activates the Glucose-dependent Mobilization of Arachidonic Acid in a Macrophage-like Cell Line (RAW 264.7) That Is Largely Mediated by Calcium-independent Phospholipase A2
1995
Aldosterone target organ protection by eplerenone
2003
Effects of Long-Term Monotherapy With Eplerenone, a Novel Aldosterone Blocker, on Progression of Left Ventricular Dysfunction and Remodeling in Dogs With Heart Failure
2002
Transgenic Model of Aldosterone-Driven Cardiac Hypertrophy and Heart Failure
2003
Substitution of Asparagine for Arginine 347 of Recombinant Factor Xa Markedly Reduces Factor Va Binding
2000
Effect of a selective aldosterone receptor antagonist in myocardial infarction
2001
Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack
2008
Structural, functional, and molecular characterization of the SHHF model of heart failure
2002
Effects of Intense Low-Density Lipoprotein Cholesterol Reduction in Patients With Stroke or Transient Ischemic Attack
2007